Strikingly, ER+ and TNBC subtypes exhibited significantly higher RPL31+ subset than FOSB+ subset, whereas the HER2+ subtype exhibited a higher FOSB+ subset than RPL31+ subset (Fig. 1M), indicating that the imbalance of these two subsets might influence the prognosis of breast cancer patients. The gene discussed is ERBB2; the disease is breast cancer.